Seguir
Monserrat Perez-Navarro
Monserrat Perez-Navarro
Hospital General de México "Dr. Eduardo Liceaga"
No hay ninguna dirección de correo electrónico verificada.
Título
Citado por
Citado por
Año
Factors associated to pulmonary tuberculosis in patients with diabetes mellitus from Veracruz, Mexico
LM Pérez-Navarro, F Fuentes-Domínguez, J Morales-Romero, ...
Gaceta medica de Mexico 147 (3), 219-225, 2011
84*2011
The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes
LM Perez-Navarro, BI Restrepo, FJ Fuentes-Dominguez, R Duggirala, ...
Tuberculosis 103, 83-91, 2017
632017
Mortality in patients with chronic renal disease without health insurance in Mexico: opportunities for a national renal health policy
R Valdez-Ortiz, F Navarro-Reynoso, MG Olvera-Soto, G Martin-Alemañy, ...
Kidney international reports 3 (5), 1171-1182, 2018
572018
Type 2 diabetes mellitus and its influence in the development of multidrug resistance tuberculosis in patients from southeastern Mexico
LM Pérez-Navarro, FJ Fuentes-Domínguez, R Zenteno-Cuevas
Journal of Diabetes and its Complications 29 (1), 77-82, 2015
552015
Effect of oral nutritional supplementation with and without exercise on nutritional status and physical function of adult hemodialysis patients: a parallel controlled clinical …
G Martin-Alemañy, M de los Ángeles Espinosa-Cuevas, M Pérez-Navarro, ...
Journal of Renal Nutrition 30 (2), 126-136, 2020
312020
Assessment of urinary TWEAK levels in Mexican patients with untreated lupus nephritis: an exploratory study
F Reyes-Martínez, M Pérez-Navarro, A Rodríguez-Matías, ...
Nefrologia 38 (2), 152-160, 2018
232018
Description of the population structure and genetic diversity of tuberculosis in Estado de México, a low prevalence setting from Mexico
R Zenteno‐Cuevas, F Mendoza‐Damián, IC Muñoz, L Enciso‐Moreno, ...
Apmis 123 (2), 116-122, 2015
192015
A first insight into the genetic diversity of Mycobacterium tuberculosis in Veracruz, Mexico
R Almaraz-Velasco, D Munro-Rojas, J Fuentes-Domínguez, ...
The International Journal of Mycobacteriology 6 (1), 14-20, 2017
172017
Effect of intradialytic oral nutritional supplementation with or without exercise improves muscle mass quality and physical function in hemodialysis patients: a pilot study
G Martin-Alemañy, M Perez-Navarro, KR Wilund, G García-Villalobos, ...
Nutrients 14 (14), 2946, 2022
132022
Consenso experto en tiempos de COVID-19: aplicaciones del método Delphi en materia de salud
JD Martínez-Ezquerro, SM Ruiz-Cejudo, A Bustamante-Fuentes, ...
Cirugía y cirujanos 89 (1), 120-129, 2021
112021
Characterisation of pks15/1 in clinical isolates of Mycobacterium tuberculosis from Mexico
R Zenteno-Cuevas, FX Silva-Hernández, F Mendoza-Damián, ...
Memórias do Instituto Oswaldo Cruz 108, 718-723, 2013
102013
Cómo se puede estimar el tamaño de la muestra de un estudio
JCL Alvarenga, AR Bernal, MP Navarro, SS Cossio
Dermatología Revista Mexicana 54 (6), 375-379, 2010
102010
Clinical significance of serum uric acid levels in Mexican young adults
A Alegría-Díaz, R Valdez-Ortiz, M Murguía-Romero, R Jiménez-Flores, ...
Uric Acid in Chronic Kidney Disease 192, 125-134, 2018
82018
Factors of poor prognosis associated with chronic kidney disease by stage in ambulatory patients: a cross-sectional study
RV Ortiz, S Escorza-Valdivia, S Benitez-Renteria, JC Lopez-Alvarenga, ...
Archives of Medical Research 53 (5), 524-532, 2022
62022
A rapid PCR assay to characterize the intact pks15/1 gene, a virulence marker in Mycobacterium tuberculosis
R Zenteno-Cuevas, RJ Hernandez-Morales, LM Pérez-Navarro, ...
Journal of microbiological methods 121, 33-35, 2016
62016
Thrombotic microangiopathy in patients with diabetic nephropathy is associated with low VEGF expression and end-stage renal disease
K Hernández-Arteaga, V Soto-Abraham, M Pérez-Navarro, ...
Clin Nephrol 89 (6), 429-437, 2018
52018
Changes in lactate dehydrogenase on admission throughout the COVID-19 pandemic and possible impacts on prognostic capability
EO Medina-Hernández, LM Pérez-Navarro, J Hernández-Ruiz, ...
Biomarkers in Medicine 16 (14), 1019-1028, 2022
42022
A Randomized, Controlled Study on the Safety and Efficacy of Maraviroc and/or Favipiravir vs Currently Used Therapy in Severe COVID-19 Adults.“COMVIVIR” Trial.
A Pérez-García, A Villalobos-Osnaya, ML Hernández-Medel, ...
42020
Cardiometabolic risk factors associated with renal function in apparently healthy young students: a cross-sectional study
LM Pérez-Navarro, R Valdez-Ortiz, A Alegría-Díaz, M Murguía-Romero, ...
Revista de investigación clínica 72 (2), 95-102, 2020
42020
Factores asociados a tuberculosis pulmonar en pacientes con diabetes mellitus de Veracruz
LM Perez Navarro, F Fuentes Dominguez, J Morales-Romero, ...
México–2011, 2011
42011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20